Proposal for standardization of 2019-nCoV nucleic acid detection in clinical laboratories
Chinese J. Lab. Med.
; 3(43):209-212, 2020.
Article
in Chinese
| ELSEVIER | ID: covidwho-769460
ABSTRACT
In December, the outbreak of a novel coronavirus (2019-nCoV) in Wuhan, China, has attracted extensive global attention. On January 20, 2020, the Chinese health authorities upgraded the coronavirus to a Class B infectious disease in the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and considered it as Class A infectious diseases in disease control and prevention. On January 18, 2020, the 2019-nCoV nucleic acid detection test was listed as the diagnostic criteria in the "guidelines for diagnosis and treatment of pneumonia due to 2019-nCoV (Trial Version 2)". Therefore, standardizing the operation process of the 2019-nCoV nucleic acid detection in clinical laboratories has become a top priority. It is of paramount importance to establish standard protocols for detection of the 2019-nCoV nucleic acids in clinical laboratories to improve the reliability of the results and ensure the biosafety of laboratory personnel.
Full text:
Available
Collection:
Databases of international organizations
Database:
ELSEVIER
Type of study:
Prognostic study
/
Randomized controlled trials
Language:
Chinese
Journal:
Chinese J. Lab. Med.
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS